Bisphosphonate-Induced Osteonecrosis: Fact or Fracture?

Wang J Goodger NM Pogrel MA . Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61(9):1104–7.

Gutta R Louis PJ . Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):186–93.

Mehrotra B Ruggiero S . Bisphosphonate complications including osteonecrosis of the jaw. Hematology Am Soc Hematol Educ Program 2006;356–60.

Lam DK Sándor GK Holmes HI A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 2007;73(5):417–22.

Chaiamnuay S Saag KG . Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates? Rev Endocr Metab Disord 2006;7(1–2):101–12.

Woo SB Hellstein JW Kalmar JR . Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753–61.

Bilezikian J . Osteonecrosis of the jaw — do bisphosphonates pose a risk? N Engl J Med 2006;355(22):2278–81.

Woelfel JA Tom WC . Bisphosphonates and jaw bone damage. Pharmacist's Letter 2006;22(8):220801.

Weinberg MA . Bisphosphonate-associated osteonecrosis of the jaws. US Pharm 2006;31(8):62–9.

Hewitt C Farah CS . Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 2007;36(6):319–28.

Teng MS Futran ND . Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg 2005;13(4):217–21.

Coskunfirat OK Wei FC Huang WC Microvascular free tissue transfer for treatment of osteoradionecrosis of the maxilla. Plast Reconstr Surg 2005;115(1):54–60.

Krueger CD West PM Sargent M Bisphosphonate-induced osteonecrosis of the jaw. Ann Pharmacother 2007; 41:276–84.

Durie BG Katz M Crowley J . Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99–102.

Ruggiero SL Mehrotra B Rosenberg TJ Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):527–34.

Malden NJ Pai AY . Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 2007;203(2):93–7.

American Association of Oral and Maxillofacial Surgeons — position paper on bisphosphonate-related osteonecrosis of the jaws. Available: http://aaoms.org/docs/position_papers/osteonecrosis.pdf (accessed September 17, 2007).

Wooltorton E . Patients receiving intravenous bisphosphonates should avoid invasive dental procedures. CMAJ 2005;172(13):1684.

Bamias A Kastritis E Bamia C Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005;23(34):8580–7.

Migliorati CA Casiglia J Epstein J Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005;136(12):1658–68.

American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 2006;137(8):1144–50.

Epstein J Klasser GD Migliorati CA . Point of care. J Can Dent Assoc 2005;71(9):638–9. Available: www.cda-adc.ca/_files/mem-bers/news_publications/member/pdfs/poc_oct_2005.pdf (accessed October 6, 2008).

National Osteoporosis Foundation. Osteonecrosis of the jaw. Available: www.nof.org/patientinfo/osteonecrosis.htm (accessed October 6, 2008).

Etminan M Aminzadeh K Matthew IR Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol 2008;35:691–5.

Scientific Advisory Council of Osteoporosis Canada — AON and bisphosphonates (Position Statement). Osteoporosis update 2008;12(2):6. Available: www.osteoporosis.ca/local/files/health_professionals/pdfs/osteoupdate_spring2008_e.pdf (accessed October 6, 2008).

Khan AA Sandor GK Dore E Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008;35(7):1391–7.